This page provides a summary of the PICOBOO study results, including plain language summaries, study design, methods, and final findings.
Plain Language Summaries
These summaries are designed to be easily understood by participants and the public. The version numbers and approval dates are provided for transparency.
Title: Early Results of a 2nd Booster in 50-69 Year Olds Primed with Astra Zeneca File Name: PICOBOO Plain Language Summary AZ-AZ 50-69 2nd Booster Version Number: V2.0 HREC Approval Date: 30/07/2024 READ MORE
Title: Early Results of a 2nd Booster in 18-49 and 50-69 Year Olds Primed with Pfizer File Name: PICOBOO Plain Language Summary PF-PF 18-69 2nd Booster Version Number: V2.0 HREC Approval Date: 30/07/2024 READ MORE
Study Design and Methods
These papers describe how the PICOBOO study was designed and the methods used, including important statistical considerations.
Title: Core Protocol for the Adaptive Platform Trial in COVID-19 Vaccine Priming and BOOsting Date: 18 March 2023 Journal: Trials Note: Published READ MORE
Title: Statistical Considerations for the Platform Trial in COVID-19 Vaccine Priming and Boosting Date: 22 Jul 2024 Journal: Trials Note: Published READ MORE
Title: The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol Date: 01 Nov 2024 Journal: Trials Note: Published READ MORE
Study Results
These papers present the final outcomes and findings of the PICOBOO study. Some publications are pre-prints, meaning they haven’t yet been reviewed by other experts.
Title: The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old Date: 26 Sep 2024 Journal: Journal of Infection Note: Published READ MORE
Title: The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old Date: 14 Nov 2024 Journal: Journal of Infection Note: Published READ MORE